| 产品详情 |
| Edit |   |
|---|
| Product Name | Dovitinib |
|---|
| Description | A receptor tyrosine kinase inhibitor that targets VEGF, bFGF, and PDGFβ receptors, preventing the growth and motility of various cancer cell lines and endothelial cells |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 804551-?71-?1 TKI258 TKIs 258 TKI-258 CHIRs CHIR-258 CHIR258 receptors tyrosines kinases inhibitors inhibits 804551-71-1 inhibitons proteins angiogenesis vascular endothelial growth factors VEGFR basic fibroblasts bFGFR platelet-derived platelet derived PDGFR anticancers anti-cancer anti cancers antiangiogenic angiogenic anti-angiogenic hepatocellular carcinoma HCC multi-targeted multi targeted PDGFb PDGFbeta PDGF.beta. PDGF-β PDGF-b PDGFβ PDGF-beta PDGF-.beta. PDGFs β b beta .beta. dovitinib targets factor-2 VEGFR-2 2 factor-1 signals impairing impair prevents motility pancreatic cells lines HPAF-II BxPC-3 MiaPaCa2 L3.6pl HPAF II BCPC 3 L3 6pl proliferation effects mechanisms metastasis clinical trials treatments advanced solid tumors |
|---|
| Gene, Accession, CAS # | CAS: 405169-16-6 |
|---|
| Catalog # | 15220-50 |
|---|
| Price | |
|---|
| Order / More Info | Dovitinib from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|